Senior Scientist
FDA
Silver Spring, MD, United States
Dr. Merkel received his Ph.D. from the University of Virginia and received postdoctoral training at the National Institutes of Health before establishing a research program in the Food and Drug Administration. He brings over thirty years of experience in infectious disease research and related disciplines and 20 years of vaccine regulatory experience to the study of bacterial pathogenesis and the evaluation of new vaccines. He has extensive experience developing and utilizing animal models of bacterial infections. The baboon model of pertussis, developed in Dr. Merkel’s laboratory has provided important insights into the host response to pertussis vaccination and infection. This model continues to provide the pertussis research community with the opportunity to address important questions that shed light on the pathogenesis and vaccine-mediated protection of this important pathogen and insights from this model continue to guide vaccine development and regulation.
Disclosure(s): No financial relationships to disclose
71 - New Approaches to Pertussis Vaccination
Thursday, October 12, 2023
1:45 PM – 3:00 PM US ET
947 - A Non-Human Primate Model of Pertussis Infection and Vaccination
Thursday, October 12, 2023
1:45 PM – 2:10 PM US ET